Raymond James Financial Inc. acquired a new stake in shares of Global Medical REIT Inc. (NYSE:GMRE - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 185,224 shares of the company's stock, valued at approximately $1,430,000. Raymond James Financial Inc. owned 0.28% of Global Medical REIT at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of the company. Franklin Resources Inc. grew its stake in shares of Global Medical REIT by 228.9% during the 3rd quarter. Franklin Resources Inc. now owns 114,988 shares of the company's stock worth $1,073,000 after acquiring an additional 80,030 shares during the period. Barclays PLC lifted its holdings in Global Medical REIT by 87.1% during the third quarter. Barclays PLC now owns 154,051 shares of the company's stock valued at $1,527,000 after purchasing an additional 71,704 shares during the last quarter. New Age Alpha Advisors LLC purchased a new position in shares of Global Medical REIT in the fourth quarter worth about $263,000. Aew Capital Management L P purchased a new position in shares of Global Medical REIT in the fourth quarter worth about $230,000. Finally, Proficio Capital Partners LLC bought a new stake in shares of Global Medical REIT in the fourth quarter valued at approximately $178,000. 57.52% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Separately, B. Riley began coverage on shares of Global Medical REIT in a research note on Thursday, April 3rd. They issued a "neutral" rating and a $9.00 price objective for the company.
View Our Latest Research Report on GMRE
Global Medical REIT Price Performance
Shares of GMRE traded up $0.04 during midday trading on Wednesday, hitting $7.76. 102,836 shares of the company traded hands, compared to its average volume of 442,012. The stock has a 50-day moving average of $8.10 and a 200-day moving average of $8.27. The company has a debt-to-equity ratio of 1.26, a current ratio of 0.28 and a quick ratio of 0.28. Global Medical REIT Inc. has a one year low of $6.75 and a one year high of $10.46. The firm has a market cap of $518.92 million, a P/E ratio of -386.56, a PEG ratio of 1.43 and a beta of 1.23.
Global Medical REIT (NYSE:GMRE - Get Free Report) last posted its earnings results on Thursday, February 27th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.21. The business had revenue of $35.16 million for the quarter, compared to analysts' expectations of $34.87 million. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. As a group, sell-side analysts predict that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.
Global Medical REIT Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 9th. Stockholders of record on Friday, March 21st were issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 10.82%. The ex-dividend date was Friday, March 21st. Global Medical REIT's payout ratio is 8,400.00%.
Global Medical REIT Company Profile
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Featured Stories

Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.